Structure-Based Virtual Screening Identifies Ritobegron and Resveratrol as Dual Inhibitors of NMDA and PTP-1B for Alzheimer’s Disease Therapy
2026Tropical Journal of Phytochemistry and Pharmaceutical SciencesJournalOpen access
10.26538/tjpps/v5i2.4Full text1 citations